{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:46:05Z","timestamp":1785703565069,"version":"3.56.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbrc.2026.154086","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:51:22Z","timestamp":1780530682000},"page":"154086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["KIF11 drives ovarian cancer progression and cisplatin resistance via the Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"828","author":[{"given":"Yu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12935-025-03698-x","article-title":"The emerging role of glycolysis and immune evasion in ovarian cancer","volume":"25","author":"Jin","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154086_bib2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/jcm14041236","article-title":"Giant ovarian tumors in young women: diagnostic and treatment challenges\u2014A report of two cases and narrative review of the recent literature","volume":"14","author":"Melnyk","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.154086_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1029976","article-title":"The current role of secondary cytoreductive surgery for recurrent ovarian cancer","volume":"12","author":"de Bree","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154086_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2022.8293","article-title":"Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer","volume":"47","author":"Yang","year":"2022","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154086_bib5","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.3390\/ijms24087585","article-title":"Cisplatin in ovarian cancer treatment\u2014known limitations in therapy force new solutions","volume":"24","author":"Zo\u0144","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154086_bib6","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.3390\/molecules28083407","article-title":"The challenging treatment of cisplatin-resistant tumors: state of the art and future perspectives","volume":"28","author":"Coffetti","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154086_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2478\/raon-2019-0018","article-title":"Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy","volume":"53","author":"Makovec","year":"2019","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154086_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/JEP.S267383","article-title":"Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy","author":"Tchounwou","year":"2021","journal-title":"J. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10495-024-02027-3","article-title":"SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT\/mTOR\/Autophagy pathway","volume":"30","author":"Qi","year":"2025","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154086_bib10","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s13402-024-01010-z","article-title":"IRE1\u03b1 inhibitor reduces cisplatin resistance in ovarian cancer by modulating IRE1\u03b1\/XBP1 pathway","volume":"47","author":"Lv","year":"2024","journal-title":"Cell. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13048-025-01641-2","article-title":"MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathways","volume":"18","author":"Wang","year":"2025","journal-title":"J. Ovarian Res."},{"issue":"18","key":"10.1016\/j.bbrc.2026.154086_bib12","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.3390\/ijms26188975","article-title":"Kinesin spindle protein (KIF11) in mitosis and cancer","volume":"26","author":"Silva","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154086_bib13","article-title":"KIF11 serves as an independent prognostic factor and therapeutic target for patients with lung adenocarcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0300891620988342","article-title":"High KIF11 expression is associated with poor outcome of NSCLC","volume":"108","author":"Liu","year":"2022","journal-title":"Tumori J."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154086_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7150\/ijbs.54074","article-title":"KIF11 promotes cell proliferation via ERBB2\/PI3K\/AKT signaling pathway in gallbladder cancer","volume":"17","author":"Wei","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-28773-1","article-title":"Novel m5C-dependent post-transcriptional regulation of KIF11 drives lymphatic metastasis in gastric cancer","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154086_bib17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1080\/02648725.2023.2174688","article-title":"Maximal clique centrality and bottleneck genes as novel biomarkers in ovarian cancer","volume":"39","author":"Bhattacharyya","year":"2023","journal-title":"Biotechnol. Genet. Eng. Rev."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13048-021-00837-6","article-title":"Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics","volume":"14","author":"Dong","year":"2021","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13048-020-0613-2","article-title":"Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer","volume":"13","author":"Yang","year":"2020","journal-title":"J. Ovarian Res."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154086_bib20","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/2211-5463.12492","article-title":"Death receptor 6 promotes ovarian cancer cell migration through KIF 11","volume":"8","author":"Shi","year":"2018","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","article-title":"Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy","volume":"24","author":"Wu","year":"2025","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.bbrc.2026.154086_bib22","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/jcm8101658","article-title":"Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance","volume":"8","author":"Teeuwssen","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154086_bib23","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/cancers15041275","article-title":"An overview of ovarian cancer: the role of cancer stem cells in chemoresistance and a precision medicine approach targeting the Wnt pathway with the antagonist sFRP4","volume":"15","author":"Varier","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154086_bib24","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1158\/1078-0432.CCR-21-2984","article-title":"Metabolic alterations and WNT signaling impact immune response in HGSOC","volume":"28","author":"Arend","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13048-019-0596-z","article-title":"Wnt\/\u03b2-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesis","volume":"12","author":"Nguyen","year":"2019","journal-title":"J. Ovarian Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154086_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/0115665232323373240905104033","article-title":"Characteristics of oxidative phosphorylation-related subtypes and construction of a prognostic signature in ovarian cancer","volume":"25","author":"Lu","year":"2025","journal-title":"Curr. Gene Ther."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154086_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0115665232417125251021114250","article-title":"Foxp3(+) tregs promote M2 macrophage polarization via Sirt1-ERK1\/2- STAT3 pathway in ovarian cancer progression","volume":"26","author":"Liang","year":"2026","journal-title":"Curr. Gene Ther."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154086_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4048\/jbc.2019.22.e51","article-title":"Kinesin family member 11 enhances the self-renewal ability of breast cancer cells by participating in the Wnt\/\u03b2-catenin pathway","volume":"22","author":"Pei","year":"2019","journal-title":"J. Breast Cancer"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154086_bib29","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3892\/etm.2021.10588","article-title":"ASPM combined with KIF11 promotes the malignant progression of hepatocellular carcinoma via the Wnt\/\u03b2-catenin signaling pathway","volume":"22","author":"Wu","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12967-025-06362-0","article-title":"TMEM176B inhibits ovarian cancer progression by regulating EMT via the Wnt\/\u03b2-catenin signaling pathway","volume":"23","author":"Yan","year":"2025","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154086_bib31","first-page":"345","article-title":"MiR-5590-3p inhibits the proliferation and invasion of ovarian cancer cells through mediating the Wnt\/\u03b2-catenin signaling pathway by targeting TNIK","volume":"39","author":"Wu","year":"2024","journal-title":"Histol. Histopathol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154086_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2026.154086_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920913798","article-title":"Inhibition of the Wnt\/\u03b2-catenin pathway enhances antitumor immunity in ovarian cancer","volume":"12","author":"Doo","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154086_bib34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41419-023-06313-x","article-title":"Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer","volume":"14","author":"Shi","year":"2023","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154086_bib35","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s10528-024-10817-2","article-title":"Identification of MAD2L1 and BUB1B as potential biomarkers associated with progression and prognosis of ovarian cancer","volume":"63","author":"Tang","year":"2025","journal-title":"Biochem. Genet."},{"issue":"21","key":"10.1016\/j.bbrc.2026.154086_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71311","article-title":"BUB1B promotes ovarian cancer cell proliferation and metastasis by activating the Wnt\/\u03b2\u2010Catenin pathway","volume":"14","author":"Wang","year":"2025","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154086_bib37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12033-022-00463-7","article-title":"CCNB1, negatively regulated by miR-559, promotes the proliferation, migration, and invasion of ovarian carcinoma cells","volume":"64","author":"Yang","year":"2022","journal-title":"Mol. Biotechnol."},{"issue":"14","key":"10.1016\/j.bbrc.2026.154086_bib38","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1080\/15384101.2019.1624112","article-title":"Methylation-mediated repression of MiR-424\/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23","volume":"18","author":"Li","year":"2019","journal-title":"Cell Cycle"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154086_bib39","doi-asserted-by":"crossref","DOI":"10.1242\/dev.146589","article-title":"Wnt signaling in development and tissue homeostasis","volume":"145","author":"Steinhart","year":"2018","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154086_bib40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cbin.11797","article-title":"Wnt signaling pathway: a comprehensive review","volume":"46","author":"Hayat","year":"2022","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154086_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3892\/mmr.2020.11744","article-title":"Wnt\/\u03b2-catenin signaling: causes and treatment targets of drug resistance in colorectal cancer","volume":"23","author":"Zhu","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"21","key":"10.1016\/j.bbrc.2026.154086_bib42","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.3390\/cancers14215468","article-title":"Wnt\/\u03b2-Catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma","volume":"14","author":"Leung","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154086_bib43","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.7150\/thno.94943","article-title":"Mesenchymal stem cell-derived apoptotic vesicles ameliorate impaired ovarian folliculogenesis in polycystic ovary syndrome and ovarian aging by targeting WNT signaling","volume":"14","author":"Fu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2026.154086_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154602","article-title":"SOX9\/NFIA promotes human ovarian cancer metastasis through the Wnt\/\u03b2-catenin signaling pathway","volume":"248","author":"Lu","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbrc.2026.154086_bib45","article-title":"The overexpression of actin related protein 2\/3 complex subunit 1B (ARPC1B) promotes the ovarian cancer progression via activation of the Wnt\/\u03b2-catenin signaling pathway","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154086_bib46","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.3892\/etm.2016.3885","article-title":"Role of Wnt\/\u03b2-catenin, Wnt\/c-Jun N-terminal kinase and Wnt\/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer","volume":"12","author":"Huang","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrc.2026.154086_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fonc.2020.00046","article-title":"Caveolin-1 promotes chemoresistance of gastric cancer cells to cisplatin by activating WNT\/\u03b2-catenin pathway","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10238-025-01757-1","article-title":"\u03b2-catenin as a key regulator of the cisplatin response in tumor cells","volume":"25","author":"Saburi","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9390878","article-title":"Role of Wnt\/\u03b2\u2010catenin signaling in the chemoresistance modulation of colorectal cancer","volume":"2020","author":"Yuan","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2026.154086_bib50","first-page":"1","article-title":"YTHDF1-mediated m6A modification promotes cisplatin resistance in ovarian cancer via the FZD7\/Wnt\/\u03b2-catenin pathway","author":"Miao","year":"2025","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154086_bib51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10495-023-01873-x","article-title":"USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt\/\u03b2-catenin signaling pathway","volume":"29","author":"Pei","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2026.154086_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118672","article-title":"Wnt\/\u03b2-catenin agonist BIO alleviates cisplatin-induced nephrotoxicity without compromising its efficacy of anti-proliferation in ovarian cancer","volume":"263","author":"Sun","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154086_bib53","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10571-020-01038-3","article-title":"Upregulation of KIF11 in TP53 mutant glioma promotes tumor stemness and drug resistance","volume":"42","author":"Liu","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154086_bib54","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.7150\/jca.52103","article-title":"KIF11 is upregulated in colorectal cancer and silencing of it impairs tumor growth and sensitizes colorectal cancer cells to oxaliplatin via p53\/GSK3\u03b2 signaling","volume":"12","author":"Zhou","year":"2021","journal-title":"J. Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:47:29Z","timestamp":1785700049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26008508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"alternative-id":["S0006291X26008508"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154086","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KIF11 drives ovarian cancer progression and cisplatin resistance via the Wnt\/\u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154086"}}